Navigating CDSCO Medical Device Import License for Overseas Manufacturers

India’s medical device market continues to expand rapidly, driven by rising healthcare demand, government initiatives, and growing patient needs. For foreign manufacturers aiming to supply quality products here, obtaining the necessary approvals from the Central Drugs Standard Control Organization (CDSCO) is mandatory. This process is governed by the Medical Devices Rules (MDR) 2017, which established a risk-based regulatory framework for all medical devices and in-vitro diagnostics.

Understanding the Regulatory Framework

Under the Medical Devices Rules 2017, all medical devices are classified into four risk classes: Class A (low risk), Class B (low-moderate risk), Class C (moderate-high risk), and Class D (high risk). Classification follows the First Schedule of MDR 2017 and is based on intended use, duration of contact, invasiveness, and other risk factors.

Import of all classes of medical devices (except certain non-sterile, non-measuring Class A devices that only require portal registration) requires an import license issued by the Central Licensing Authority (CLA) of CDSCO. Foreign manufacturers cannot apply directly. They must appoint an Indian Authorized Agent (also called Authorized Indian Agent or IAA) who holds a valid wholesale license or manufacturing license under the rules.

Step 1: Appoint an Indian Authorized Agent

The first and most critical step is appointing a suitable Indian Authorized Agent. As per Rule 34 and related provisions of MDR 2017, the agent must be an Indian legal entity possessing a valid license for wholesale or manufacture of medical devices (typically Form MD-42 or equivalent).

The appointment is formally established by means of a Power of Attorney (PoA).

This document must be notarized and apostilled (or authenticated by the Indian Embassy/Consulate in the country of origin) and include an undertaking from the agent. The agent becomes the legal point of contact with CDSCO, submits applications, responds to queries, handles post-market obligations, and assumes regulatory responsibilities in India.

Choosing an experienced agent with proven CDSCO experience, strong documentation capabilities, and no conflicts of interest significantly reduces delays and compliance risks.

Step 2: Confirm Device Classification and Regulatory Pathway

Accurate classification is essential. Refer to the official CDSCO classification lists and the risk-based criteria in the First Schedule of MDR 2017. Wrong classification leads to incorrect documentation requirements and potential rejection.

For devices already approved in reference countries (USA, European Union, Canada, Japan, Australia, or UK in relevant contexts), the pathway is generally smoother. Class A and B devices with free sale certificates from these countries face lighter scrutiny, while Class C and D devices may still require detailed technical review or, in some cases, additional data.

Step 3: Prepare the Complete Technical Dossier

The Indian Authorized Agent compiles and submits a comprehensive dossier. Key documents typically required under the Fourth Schedule of MDR 2017 include:

• Device Master File (DMF) covering device description, intended use, specifications, variants, working principle, and labeling.
• Plant Master File (PMF) detailing the manufacturing site, quality system, and premises.
• Valid ISO 13485:2016 certificate for the quality management system.
• Free Sale Certificate (FSC) or equivalent marketing authorization from the country of origin or a reference country.
• Power of Attorney and agent’s undertaking.
• Product labels, package inserts, and Instructions for Use (in English; additional local language requirements may apply post-approval).
• Clinical evaluation data, performance evaluation reports (especially for IVDs), or substantial equivalence information where applicable.
• Constitution details of the manufacturer and any other certificates (CE, FDA clearance, etc.) as supporting evidence.

All documents must be consistent across model numbers, intended use statements, and technical specifications. Incomplete or inconsistent dossiers are the most common cause of queries and delays.

Step 4: Register on the CDSCO Online Portal and Submit Form MD-14

Applications are filed exclusively online through the CDSCO SUGAM portal (cdscoonline.gov.in) or the integrated National Single Window System (NSWS). The Indian Authorized Agent creates or uses an existing organization profile and submits the application in Form MD-14 along with the prescribed fees as per the Second Schedule of MDR 2017.

The application covers manufacturer details, manufacturing site, device classification, intended use, models/variants, and regulatory status in other countries.

Step 5: CDSCO Review, Queries, and Possible Inspection

After submission, CDSCO conducts administrative screening for completeness. Deficient applications receive deficiency letters. For higher-risk devices, technical evaluation may involve Subject Expert Committees (SEC).

The Central Licensing Authority may order an overseas manufacturing site inspection if required (particularly for certain Class C and D devices or when additional verification is needed). The applicant bears the associated costs.

Query responses must be prompt, complete, and accurate. Most timeline extensions occur during this phase.

Step 6: Grant of Import License in Form MD-15

Upon satisfactory review, CDSCO grants the import license in Form MD-15. This license is issued to the Indian Authorized Agent on behalf of the foreign manufacturer and authorizes the import of the specific devices for sale or distribution in India.

The license is generally perpetual, subject to payment of retention fees every five years. Failure to pay retention fees results in the license being deemed cancelled.

Post-Approval Obligations

After obtaining MD-15, manufacturers and their agents must ensure:

• Proper labeling compliance (including unique device identification where applicable).
• Post-market surveillance and adverse event reporting.
• Retention fee payments.
• Notification of significant changes (manufacturing site, design, intended use, etc.), which may require fresh applications or variations.
• Customs clearances supported by the valid license for each shipment.

Why Choose Professional Regulatory Support?

Navigating CDSCO requirements involves precise interpretation of MDR 2017, meticulous document preparation, portal expertise, and effective query management. Errors in classification, incomplete dossiers, or delayed responses can extend timelines from several months to over a year, especially for Class C and D devices.

How MDR Consultants Can Help You Succeed

At MDR CONSULTANTS, we specialize in end-to-end support for foreign manufacturers seeking medical device registration in India. Our team provides:

• Accurate device classification and regulatory pathway assessment.
• Appointment guidance and Power of Attorney preparation.
• Complete dossier compilation including DMF and PMF aligned with Fourth Schedule requirements.
• Seamless Form MD-14 submission via the SUGAM portal.
• Proactive query handling and liaison with CDSCO.
• Post-approval compliance support, including retention and change management.

We stay updated with the latest CDSCO notifications, circulars, and amendments to MDR 2017, ensuring your application reflects current expectations. Our focused expertise in import licenses helps overseas companies achieve faster, more predictable market entry while maintaining full regulatory compliance.

Conclusion

Successfully registering medical devices for import into India requires a structured approach under the Medical Devices Rules 2017: appointing a qualified Indian Authorized Agent, confirming risk classification, preparing a robust technical dossier, submitting Form MD-14 through the official online portal, and securing the Form MD-15 import license from CDSCO. Attention to documentation quality, consistency, and timely responses remains the key to avoiding delays.

Foreign manufacturers who treat regulatory compliance as a strategic priority rather than a mere formality gain smoother access to one of the world’s most promising healthcare markets. Partnering with experienced consultants like MDR CONSULTANTS further streamlines the journey, reduces risk, and positions your products for long-term success in India.

Whether you are preparing your first application or expanding an existing portfolio, following these CDSCO-aligned steps will help you move confidently from planning to approved import and distribution.

Last Updated : 11 Sep 2026